Catalyst Wire Dossier Catalyst Wire Dossier

Flublok

influenza vaccine, recombinant · Sanofi Pasteur
Drug timelines are a Plus or Pro feature.

12 regulatory and trial events tracked for Flublok, covering 2009-12-17 to 2025-05-28. Get the full timeline:

Most recent: Clinical Trial Update: Study of a Combination Vaccine Comprised of Different Recombinant Spike Antigen Levels of a Matrix-M Adjuvanted Recombinant COVID-19 Vaccine and Recombinant Influenza Vaccine in Adult Participants 50 Years of Age and Older [Phase 1, Phase 2]

See pricing